Medscape
The Medicines and Healthcare products Regulatory Agency (MHRA) has reminded healthcare professionals to warn patients about common and serious side effects associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs). Simultaneously, the House of Lords food, diet, and obesity committee declared a public health emergency on obesity and diet-related diseases and recommended a tax on on junk …
Read More
MHRA Warns of Weight Loss Drug Side Effects
The Medicines and Healthcare products Regulatory Agency (MHRA) has reminded healthcare professionals to warn patients about common and serious side effects associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs). Simultaneously, the House of Lords food, diet, and obesity committee declared a public health emergency on obesity and diet-related diseases and recommended a tax on on junk